Companies/AU/CUV

CLINUVEL PHARMACEUTICALS LIMITED

Last · ASXA$7.32-0.29 (-3.81%)close · yahoo · 6h ago
Vol 210.7K ≈ 1.54M
Market capA$369.6M50.5M sh
P/E · TTM10.9fwd 10.3 · eps 0.67
Beta0.58vs S&P 500
Div yield0.66%annual · TTM
52w range
A$7.08A$13.48
Volume210.7Ksession

Issuer

Legal nameCLINUVEL PHARMACEUTICALS LIMITED
HQAustralia (AU)
ListingAU CUV
ISINAU000000CUV3
LEI5299004VJH3VCYLK6519
SectorHealthcare
IndustryPharmaceuticals
CurrencyAUD
Entity registryisin:AU000000CUV3
Websitewww.clinuvel.com
LinkedIn
Employees16
AddressClinuvel Pharmaceuticals Ltd. 535 Bourke Street 3000, Melbourne +61 3 9660 4900
Headline financial metrics
RevenueA$78.3M
Net incomeA$47.7M
Net margin60.9%
Loading chart…

Press & signals

2 recent
  • GlobeNewswire

    A decade of profitability provides foundation for CLINUVEL’s U.S. expansion

  • GlobeNewswire

    CLINUVEL implements strategic reorganisation to refocus on U.S. markets

Documents

FormReporting forFiledFlags
CUVNotification of cessation of securities - CUV
—2026-10-140
CUVApplication for quotation of securities - CUV
—2026-10-050
CUVNotification of cessation of securities - CUV
—2026-10-050
DISCLOSURESection 708A Cleansing Statement
—2026-10-050
SC 13DChange in substantial holding
—2026-10-020
Showing 5 of 39 filings